Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated Type 2 Diabetes Mellitus
1 other identifier
observational
300
1 country
1
Brief Summary
The objective of present study were to compare plasma adiponectin isoform status, their bioactivities newly diagnosed Chinese with healthy volunteer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 11, 2011
CompletedFirst Posted
Study publicly available on registry
June 14, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 14, 2011
May 1, 2010
1.4 years
June 11, 2011
June 13, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
plasma adiponectin concentration, isoform distribution and activity.
participants will be followed for the duration of hospital stay, an expected average of 1 week
Study Arms (2)
T2DM patients
newly diagnosed T2DM patients and untreated with any drugs.
Non-diabetic Control Group
Eligibility Criteria
This study enrolls a group of 30-70years patients from primary care clinic who have diabetes history within 12 months and without taking any treatment.
You may qualify if:
- Having a diabetic history within 12 months
- BMI smaller than 30kg/m2
You may not qualify if:
- Having any kinds of treatment affecting glucose
- pregnant
- uncontrolled hypertension, active cardiac disease, or other major liver, kidney disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Xijing Hospital
Xi'an, Shaanxi, 710032, China
Biospecimen
blood，abdominal fat tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ling Tao, M.D Ph.D
Department of Cardiology of Xijing Hospital, Fourth Military Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 11, 2011
First Posted
June 14, 2011
Study Start
May 1, 2010
Primary Completion
October 1, 2011
Study Completion
December 1, 2011
Last Updated
June 14, 2011
Record last verified: 2010-05